These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32547691)

  • 1. Systemic review and network meta-analysis: Prophylactic antibiotic therapy for spontaneous bacterial peritonitis.
    Faust N; Yamada A; Haider H; Komaki Y; Komaki F; Micic D; Sakuraba A
    World J Hepatol; 2020 May; 12(5):239-252. PubMed ID: 32547691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotics for prophylaxis of spontaneous bacterial peritonitis: systematic review & Bayesian network meta-analysis.
    Soni H; Kumar-M P; Sharma V; Bellam BL; Mishra S; Mahendru D; Mandavdhare HS; Medhi B; Dutta U; Singh V
    Hepatol Int; 2020 May; 14(3):399-413. PubMed ID: 32266675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norfloxacin, ciprofloxacin, trimethoprim-sulfamethoxazole, and rifaximin for the prevention of spontaneous bacterial peritonitis: a network meta-analysis.
    Wang W; Yang J; Liu C; Song P; Wang W; Xu H; Xia X
    Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):905-910. PubMed ID: 31107737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of long-term antibiotic treatments in the primary prophylaxis of spontaneous bacterial peritonitis.
    Facciorusso A; Papagiouvanni I; Cela M; Buccino VR; Sacco R
    Liver Int; 2019 Aug; 39(8):1448-1458. PubMed ID: 30920712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norfloxacin versus alternative antibiotics for prophylaxis of spontaneous bacteria peritonitis in cirrhosis: a systematic review and meta-analysis.
    Song S; Yang Y; Geng C; Tang Z; Wang C; Li X
    BMC Infect Dis; 2023 Aug; 23(1):557. PubMed ID: 37641014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis.
    Goel A; Rahim U; Nguyen LH; Stave C; Nguyen MH
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1029-1036. PubMed ID: 28994123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifaximin Vs. Norfloxacin for Spontaneous Bacterial Peritonitis Prophylaxis: A Randomized Controlled Trial.
    Praharaj DL; Premkumar M; Roy A; Verma N; Taneja S; Duseja A; Dhiman RK
    J Clin Exp Hepatol; 2022; 12(2):336-342. PubMed ID: 35535057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Rifaximin in Prophylaxis of Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-analysis.
    Menshawy A; Mattar O; Barssoum K; AboEl-Naga AM; Salim HM; Mohamed AMF; Elgebaly A; Abd-Elsalam S
    Curr Drug Targets; 2019; 20(4):380-387. PubMed ID: 30246636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Norfloxacin Prophylaxis to Prevent Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-Analysis.
    Mücke MM; Mücke VT; Graf C; Schwarzkopf KM; Ferstl PG; Fernandez J; Zeuzem S; Trebicka J; Lange CM; Herrmann E
    Clin Transl Gastroenterol; 2020 Aug; 11(8):e00223. PubMed ID: 32955202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.
    Assem M; Elsabaawy M; Abdelrashed M; Elemam S; Khodeer S; Hamed W; Abdelaziz A; El-Azab G
    Hepatol Int; 2016 Mar; 10(2):377-85. PubMed ID: 26660707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.
    Elfert A; Abo Ali L; Soliman S; Ibrahim S; Abd-Elsalam S
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1450-1454. PubMed ID: 27512927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in liver cirrhosis: systematic review.
    Pimentel R; Gregório C; Figueiredo P
    Acta Gastroenterol Belg; 2021; 84(2):333-342. PubMed ID: 34217185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifaximin versus norfloxacin for prevention of spontaneous bacterial peritonitis: a systematic review.
    Sidhu GS; Go A; Attar BM; Mutneja HR; Arora S; Patel SA
    BMJ Open Gastroenterol; 2017; 4(1):e000154. PubMed ID: 28944070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients.
    Mostafa T; Badra G; Abdallah M
    Turk J Gastroenterol; 2015 Mar; 26(2):163-9. PubMed ID: 25835116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Rifaximin in Spontaneous Bacterial Peritonitis Prevention.
    Oliver A; Wong M; Sanchez C
    South Med J; 2018 Nov; 111(11):660-665. PubMed ID: 30392000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis.
    Kamal F; Khan MA; Khan Z; Cholankeril G; Hammad TA; Lee WM; Ahmed A; Waters B; Howden CW; Nair S; Satapathy SK
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1109-1117. PubMed ID: 28763340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial.
    Pande C; Kumar A; Sarin SK
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):831-9. PubMed ID: 22522141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prophylaxis for spontaneous bacterial peritonitis is linked to antibiotic resistance in the Veterans Health Administration.
    Badal BD; Silvey S; Dragilev L; O'Leary JG; Morgan TR; Cheung R; Patel A; Rogal S; Patton H; Nobbe A; Jakab SS; Liu J; Patel N; Bajaj JS
    Hepatology; 2023 Jun; 77(6):2030-2040. PubMed ID: 36645215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous bacterial peritonitis recurrence in patients with cirrhosis receiving secondary prophylaxis with norfloxacin.
    Marciano S; Dirchwolf M; Diaz JM; Bermudez C; Gutierrez-Acevedo MN; Barcán LA; Smud A; Giunta D; Gadano AC
    Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):540-546. PubMed ID: 30557229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis.
    Lontos S; Gow PJ; Vaughan RB; Angus PW
    J Gastroenterol Hepatol; 2008 Feb; 23(2):252-5. PubMed ID: 17559367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.